RxDoctor Payments DataLook up a doctor →

Veltassa: payments to doctors

Payments that named Veltassa as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$6.1M
Providers
13,372
Transactions
80,072
Average per transaction
$76

The per-transaction average — $76 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,372 providers the average total is $457, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Relypsa, Inc.$3,097,32250.7%
Vifor Pharma, Inc.$2,473,83340.5%
Vifor (international) Ltd.$458,4347.5%
Vifor Fresenius Medical Care Renal Pharma Ltd.$79,0771.3%
← All drugs & devices